Results 311 to 320 of about 2,729,076 (335)

An E2 sub-unit marker vaccine does not prevent horizontal or vertical transmission of classical swine fever virus.

Vaccine, 2001
J. Dewulf, H. Laevens, F. Koenen, K. Mintiens, A. de Kruif   +4 more
semanticscholar   +1 more source

[Principles of IBR marker vaccines].

Tijdschrift voor diergeneeskunde, 1995
openaire   +1 more source

Viruses as vaccine vectors for infectious diseases and cancer

Nature Reviews Microbiology, 2009
Simon J. Draper
exaly  

Development of a classical swine fever subunit marker vaccine and companion diagnostic test.

Veterinary Microbiology, 2000
Rob J. M. Moormann, Annemarie Bouma, J. A. Kramps, Catharinus Terpstra, Hans de Smit   +4 more
semanticscholar   +1 more source

Cedivac-FMD, a marker vaccine?

2008
Chenard, G., Orsel, K., Selman, P.J., Louwes, H.D., Dekker, A.   +4 more
openaire   +1 more source

Recent progress in the diagnosis and treatment of ovarian cancer

Ca-A Cancer Journal for Clinicians, 2011
exaly  

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

Nature Reviews Microbiology, 2009
Lanying Du, Yuxian He, Yusen Zhou
exaly  

Efficacy of the classical swine fever (CSF) marker vaccine Porcilis Pesti in pregnant sows.

Veterinary Microbiology, 2000
U. Ahrens, V. Kaden, C. Drexler, N. Visser   +3 more
semanticscholar   +1 more source

Classical swine fever (CSF) marker vaccine. Trial II. Challenge study in pregnant sows.

Veterinary Microbiology, 2001
K. Depner, A. Bouma, F. Koenen, D. Klinkenberg, E. Lange, Hans de Smit, H. Vanderhallen   +6 more
semanticscholar   +1 more source

American Cancer Society’s report on the status of cancer disparities in the United States, 2023

Ca-A Cancer Journal for Clinicians
Farhad Islami, Hyunjung Lee, K Robin Yabroff   +2 more
exaly